CpG DNA: a Pathogenic Factor in Systemic Lupus Erythematosus?

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 1995 Nov 1

PMID 8576314

Citations 32

Authors

A M Krieg

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is a multifactorial disease of unknown etiology. Characteristic features of SLE include (1) polyclonal B cell activation, (2) overexpression of the immune stimulatory cytokine interleukin-6 (IL-6), (3) defective tolerance to self antigens, and (4) production of anti-DNA antibodies (Ab). Bacterial infection has been suspected as a triggering factor for lupus. Bacterial DNA differs from vertebrate DNA in the frequency and methylation of CpG dinucleotides. These CpG motifs in bacterial DNA induce a variety of immune effects, including (1) polyclonal activation of murine and human B cells, (2) IL-6 secretion, and (3) resistance to apoptosis, thereby potentially allowing the survival of autoreactive cells. These results suggest that microbial DNA could therefore be a pathogenic factor in SLE. SLE patients have elevated levels of circulating plasma DNA which is reportedly enriched in hypomethylated CpGs. Genomic DNA is also hypomethylated in SLE. The purpose of this review is to summarize the immune effects of CpG motifs and to present the evidence for their possible involvement in the pathogenesis of SLE.

Citing Articles

Locus-Specific Bisulfate NGS Sequencing of GSTP1, RNF219, and KIAA1539 Genes in the Total Pool of Cell-Free and Cell-Surface-Bound DNA in Prostate Cancer: A Novel Approach for Prostate Cancer Diagnostics.

Bryzgunova O, Bondar A, Ruzankin P, Tarasenko A, Zaripov M, Kabilov M Cancers (Basel). 2023; 15(2).

PMID: 36672380 PMC: 9856824. DOI: 10.3390/cancers15020431.

The Immunomodulatory Functions of Various CpG Oligodeoxynucleotideson CEF Cells and HN Subtype Avian Influenza Virus Vaccination.

Li C, Huang X, Cai J, Lu A, Hao S, Zhang Z Vaccines (Basel). 2022; 10(4).

PMID: 35455365 PMC: 9028402. DOI: 10.3390/vaccines10040616.

Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment.

Watanabe T Cancers (Basel). 2022; 14(1).

PMID: 35008305 PMC: 8750340. DOI: 10.3390/cancers14010141.

Morbid Sequences Suggest Molecular Mimicry between Microbial Peptides and Self-Antigens: A Possibility of Inciting Autoimmunity.

Pahari S, Chatterjee D, Negi S, Kaur J, Singh B, Agrewala J Front Microbiol. 2017; 8:1938.

PMID: 29062305 PMC: 5640720. DOI: 10.3389/fmicb.2017.01938.

Epigenomics of autoimmune diseases.

Gupta B, Hawkins R Immunol Cell Biol. 2015; 93(3):271-6.

PMID: 25776989 PMC: 7375206. DOI: 10.1038/icb.2015.18.

References

Lahat N, AGHAI E, Maroun B, Kinarty A, Quitt M, Froom P . Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity. Clin Exp Immunol. 1991; 85(2):302-6. PMC: 1535733. DOI: 10.1111/j.1365-2249.1991.tb05723.x. View

Krown S . Interferons and interferon inducers in cancer treatment. Semin Oncol. 1986; 13(2):207-17. View

Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B . Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol. 1988; 140(7):2197-200. View

Raptis L, Menard H . Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980; 66(6):1391-9. PMC: 371625. DOI: 10.1172/JCI109992. View

Bennett R, Gabor G, Merritt M . DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J Clin Invest. 1985; 76(6):2182-90. PMC: 424340. DOI: 10.1172/JCI112226. View

Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M . Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 1990; 33(11):1665-73. DOI: 10.1002/art.1780331109. View

Gilkeson G, Pippen A, Pisetsky D . Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest. 1995; 95(3):1398-402. PMC: 441482. DOI: 10.1172/JCI117793. View

Hefeneider S, Cornell K, Brown L, Bakke A, McCoy S, Bennett R . Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol. 1992; 63(3):245-51. DOI: 10.1016/0090-1229(92)90229-h. View

Lerner R, Meinke W, Goldstein D . Membrane-associated DNA in the cytoplasm of diploid human lymphocytes. Proc Natl Acad Sci U S A. 1971; 68(6):1212-6. PMC: 389156. DOI: 10.1073/pnas.68.6.1212. View

10.

Zhao Q, Waldschmidt T, Fisher E, Herrera C, Krieg A . Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors. Blood. 1994; 84(11):3660-6. View

11.

Talmadge J, Adams J, Phillips H, Collins M, Lenz B, Schneider M . Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res. 1985; 45(3):1058-65. View

12.

Agrawal S, Temsamani J, Tang J . Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci U S A. 1991; 88(17):7595-9. PMC: 52348. DOI: 10.1073/pnas.88.17.7595. View

13.

Rumore P, Muralidhar B, Lin M, Lai C, Steinman C . Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol. 1992; 90(1):56-62. PMC: 1554541. DOI: 10.1111/j.1365-2249.1992.tb05831.x. View

14.

Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y . Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 1984; 72(4):955-62. View

15.

Geselowitz D, Neckers L . Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res Dev. 1992; 2(1):17-25. DOI: 10.1089/ard.1992.2.17. View

16.

Terada K, OKUHARA E, Kawarada Y . Antigen DNA isolated from immune complexes in plasma of patients with systemic lupus erythematosus hybridizes with the Escherichia coli lac Z gene. Clin Exp Immunol. 1991; 85(1):66-9. PMC: 1535730. DOI: 10.1111/j.1365-2249.1991.tb05683.x. View

17.

Steinman C . Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest. 1984; 73(3):832-41. PMC: 425087. DOI: 10.1172/JCI111278. View

18.

Dennin R . DNA of free and complexed origin in human plasma: concentration and length distribution. Klin Wochenschr. 1979; 57(9):451-6. DOI: 10.1007/BF01477498. View

19.

Ewel C, Urba W, Kopp W, Smith 2nd J, Steis R, Rossio J . Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res. 1992; 52(11):3005-10. View

20.

Yakubov L, Deeva E, Zarytova V, Ivanova E, Ryte A, Yurchenko L . Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?. Proc Natl Acad Sci U S A. 1989; 86(17):6454-8. PMC: 297862. DOI: 10.1073/pnas.86.17.6454. View